Business & Finance
Citi tells investors it’s time to sell Moderna after 600%-plus stock gains
Key Points
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.
[Image text:] modernd
this changes everything